Category:
Carcinomas
Cancer type:
Esophogeal
Descriptor:
Poor Prognosis
Reference Number:
405
Tuynman JB, Buskens CJ, Kemper K, ten Kate FJ, Offerhaus GJ, Richel DJ, van Lanschot JJ. Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
Ann Surg. 242, 840-9 (2005)
PubMed link
Reference Number:
487
Anderson MR, Harrison R, Atherfold PA, Campbell MJ, Darnton SJ, Obszynska J, Jankowski JA. Met receptor signaling: a key effector in esophageal adenocarcinoma.
Clin Cancer Res.
12, 5936-43 (2006)
PubMed link
